Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease

Clinical trial NCT03304821 · COMPLETED

Trial details

NCT number: NCT03304821
Sponsor: Emory University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Peripheral Artery Disease (PAD)

Start date: 2017-12-19
Primary completion: 2025-07-05
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.